In pharmacogenomics, genomic information is used to study individual responses to drugs. When a gene variant is associated with a particular drug response in a patient, there is the potential for making clinical decisions based on genetics by adjusting the dosage or choosing a different drug. Modern approaches include multigene analysis or whole-genome single nucleotide polymorphism (SNP) profiles, and these approaches are just coming into clinical use for drug discovery and development.
Candidates with MBBS, BDS, B. Pharm, B.Tech. (Biotechnology), Postgraduate degree in Biomedical Sciences/ Biotechnology or any other equivalent degree is eligible to apply for this course.